CollPlant Biotechnologies Announces Private Placement of 7,647,061 Shares

CollPlant Biotechnologies announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 7,647,061 of the company's ordinary shares, unregistered series A warrants to purchase up to 7,647,061 ordinary shares and unregistered series B warrants to purchase up to 15,294,122 ordinary shares, in a private placement at a combined purchase price of 34c per ordinary share and accompanying warrants. The series A warrants will have an exercise price of 34c per share, will be exercisable on the date of shareholder approval and will expire two years after the effective date of a registration statement registering the shares issuable upon exercise of the warrants. The series B warrants will have an exercise price of 34c per share, will be exercisable on the Shareholder Approval Date and will expire five years after the effective date of a registration statement registering the shares issuable upon exercise of the warrants. The private placement is expected to close on or about July 1. H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement.